Trial Profile
Prospective, Randomized Open Trial to Evaluate the Efficacy of Highly Purified Urinary FSH Versus Recombinant FSH in Oocyte Donors Undergoing Controlled Ovarian Stimulation Based on Receptor N680S FSH Gene Polymorphism. Genodon Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Follicle stimulating hormones (Primary) ; Follitropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms GENODON
- 27 Aug 2018 Planned End Date changed from 1 Sep 2017 to 1 Mar 2019.
- 27 Aug 2018 Planned primary completion date changed from 1 Aug 2017 to 1 Jan 2019.
- 01 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Sep 2017.